Form 4: CV Sciences Director Acquires 500,000 Stock Options

James Michael Corroon Jr., a director of CV Sciences, Inc., acquired 500,000 stock options on February 18, 2025.

Summary

• James Michael Corroon Jr., a director of CV Sciences, Inc., filed a Form 4 on February 20, 2025, reporting a transaction.
• On February 18, 2025, Corroon acquired 500,000 stock options with an exercise price of $0.0375.
• These options vest on April 30, 2026, contingent upon continued service.
• The options expire on February 17, 2035.
• The reporting person now beneficially owns 500,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which can be seen as a positive incentive for the director but doesn't necessarily indicate a significant change in the company's outlook.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the options is contingent upon continued service, suggesting an incentive for the director to remain with the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the director to align their interests with the company's success.

Key Dates

Keywords

Form 4, CV Sciences, Stock Options, Director, Beneficial Ownership, CVSI